abrdn Life Sciences Investors remains a buy for high-yield seekers, offering a 10.1% dividend yield and diversified healthcare exposure. HQL trades at a 7.92% discount to NAV, with its share price ...

Update 7/31/25 4:10pm PT: Hours after this article was published, OpenAI said it removed the feature from ChatGPT that allowed users to make their public conversations discoverable by search engines.

Google’s Robby Stein shares new details about the query fan-out technique in AI Mode, explaining how Google generates and executes its own queries. Google’s query fan-out technique issues multiple ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Have you ever spent hours wrestling with messy spreadsheets, trying to clean up data that just won’t cooperate? Or maybe you’ve found yourself manually merging files, painstakingly copying and pasting ...

Have you ever found yourself drowning in a sea of messy spreadsheets, spending hours manually cleaning and organizing data? For many Excel users, this is a frustratingly familiar scenario. But what if ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

HQL offers a 14.2% dividend yield and diverse exposure to healthcare and life science companies. Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price ...

Lisa joined CNET after more than 20 years as a reporter and editor. Her coverage of AI ranged from a hands-on with OpenAI's empathetic Advanced Voice Mode to in-depth explainers on LLMs, ...